Nsg 533 cardiovascular - Study guides, Class notes & Summaries

Looking for the best study guides, study notes and summaries about Nsg 533 cardiovascular? On this page you'll find 32 study documents about Nsg 533 cardiovascular.

All 32 results

Sort by

NSG533 / NSG 533 Exam 1 (Latest 2024 / 2025): Advanced Pharmacology | Complete Guide with Questions and Verified Answers | 100% Correct - Wilkes Popular
  • NSG533 / NSG 533 Exam 1 (Latest 2024 / 2025): Advanced Pharmacology | Complete Guide with Questions and Verified Answers | 100% Correct - Wilkes

  • Exam (elaborations) • 49 pages • 2024
  • Available in package deal
  • Exam 1: NSG533 / NSG 533 (Latest 2024 / 2025 Update) Advanced Pharmacology Exam Review | Complete Guide with Questions and Verified Answers | 100% Correct - Wilkes Q: What are the goals set by ACE /ACCE and are they written in stone for all patients? Answer: Primary target for glycemic control is HbA1C Individualize HbA1C goal - based on...Duration of DM Age /life expectancy Comorbid conditions Known CVD or advanced comorbid conditionsHypoglycemic unawareness Individual patient considerations Q:...
    (1)
  • $7.99
  • 2x sold
  • + learn more
NSG 533 Cardiovascular Pathophysiology Coronary Heart Disease and Hypertension Latest Update 2024-2025 Actual Exam Questions and 100% Verified Correct Answers Guaranteed A+
  • NSG 533 Cardiovascular Pathophysiology Coronary Heart Disease and Hypertension Latest Update 2024-2025 Actual Exam Questions and 100% Verified Correct Answers Guaranteed A+

  • Exam (elaborations) • 13 pages • 2024
  • NSG 533 Cardiovascular Pathophysiology Coronary Heart Disease and Hypertension Latest Update Actual Exam Questions and 100% Verified Correct Answers Guaranteed A+
    (0)
  • $20.49
  • + learn more
NSG 533 Cardiovascular Pathophysiology- Coronary Heart Disease and Hypertension Review Questions with Answers
  • NSG 533 Cardiovascular Pathophysiology- Coronary Heart Disease and Hypertension Review Questions with Answers

  • Exam (elaborations) • 12 pages • 2024
  • Which dyslipidemia conditions are associated with CHD risk? Elevated LDL-C Low HDL-C Hypertriglyceridemia Which lipoprotein is the largest? Chylomicrons which are derrived from the fat that we eat and is made in the intestines In the absence of other risk factors, what is the most significant concern for atherosclerosis and premature CAD? Family History Name three non-modifiable risk factors for CHD - Family History - Age - Gender Modifiable risk factors of CHD - Smoking (No. 1 c...
    (0)
  • $9.99
  • + learn more
NSG 533  Module 9 Heart Failure Objectives  Rush University 2023/24
  • NSG 533 Module 9 Heart Failure Objectives Rush University 2023/24

  • Exam (elaborations) • 21 pages • 2023
  • NSG 533 Advanced Pathophysiology Cardiovascular Pathophysiology: Heart Failure 2023/24/NSG 533 Advanced Pathophysiology Cardiovascular Pathophysiology: Heart Failure 2023/24
    (0)
  • $18.99
  • + learn more
NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension Questions With Complete Solutions
  • NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension Questions With Complete Solutions

  • Exam (elaborations) • 21 pages • 2023
  • NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension Questions With Complete Solutions
    (0)
  • $12.99
  • + learn more
NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension Exam Questions and Answers 100% Pass
  • NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension Exam Questions and Answers 100% Pass

  • Exam (elaborations) • 18 pages • 2024
  • Available in package deal
  • NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension Exam Questions and Answers 100% Pass Which dyslipidemia conditions are associated with CHD risk? - Answer- Elevated LDL-C Low HDL-C Hypertriglyceridemia Which lipoprotein is the largest? - Answer- Chylomicrons which are derrived from the fat that we eat and is made in the intestines In the absence of other risk factors, what is the most significant concern for atherosclerosis and premature CAD? - Answer- Fam...
    (0)
  • $12.49
  • + learn more
NSG 533 Question and answers correctly solved
  • NSG 533 Question and answers correctly solved

  • Exam (elaborations) • 20 pages • 2024
  • NSG 533 Question and answers correctly solved NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension Which dyslipidemia conditions are associated with CHD risk? - correct answer Elevated LDL-C Low HDL-C Hypertriglyceridemia Which lipoprotein is the largest? - correct answer Chylomicrons which are derrived from the fat that we eat and is made in the intestines In the absence of other risk factors, what is the most significant concern for atherosclerosis an...
    (0)
  • $15.99
  • + learn more
NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension | 2023-2024 updated
  • NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension | 2023-2024 updated

  • Exam (elaborations) • 9 pages • 2023
  • Available in package deal
  • NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension | updated
    (0)
  • $11.49
  • + learn more
NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension Exam Questions and Answers 100% Pass
  • NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension Exam Questions and Answers 100% Pass

  • Exam (elaborations) • 18 pages • 2024
  • NSG 533: Cardiovascular Pathophysiology: Coronary Heart Disease and Hypertension Exam Questions and Answers 100% Pass Which dyslipidemia conditions are associated with CHD risk? - Answer- Elevated LDL-C Low HDL-C Hypertriglyceridemia Which lipoprotein is the largest? - Answer- Chylomicrons which are derrived from the fat that we eat and is made in the intestines In the absence of other risk factors, what is the most significant concern for atherosclerosis and premature CAD? - Answer- Fam...
    (0)
  • $13.49
  • + learn more